ISCT Webinar: The End of the FDA Enforcement Discretion Period and its Implications

When:  Jun 17, 2021 from 1:30 PM to 3:00 PM (ET)
The end of the FDA Enforcement Discretion Period for certain human cell, tissue, and tissue-based products (HCT/Ps), including regenerative medicine therapies, marks a new chapter in the regulation of stem cell clinics in the United States.

Location

Webinar